Kuros Biosciences AG (SWX:KURN)

Kuros Biosciences AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	19.77	19.76	16.89	26.03	31.4
Cash & Short-Term Investments	19.77	19.76	16.89	26.03	31.4
Cash Growth	0.03%	16.98%	-35.09%	-17.09%	-0.66%
Accounts Receivable	30.21	14.69	7.62	3.05	1.85
Other Receivables	9.98	3.01	1.43	0.87	0.39
Total Trade Receivables	40.2	17.7	9.06	3.91	2.25
Inventory	21.35	10.36	5.77	3.43	1.93
Other Current Assets	1.35	1.26	0.61	0.58	0.51
Total Current Assets	82.67	49.08	32.34	33.96	36.08
Net Property, Plant & Equipment	4.68	3.32	3.14	2.51	2.68
Other Intangible Assets	16.59	16.44	19.63	21	24.8
Goodwill	24.3	21.31	29.1	31.71	36.62
Other Long-Term Assets	5.64	2.56	0.77	0.55	-
Total Assets	133.88	92.7	84.98	89.72	100.18

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	13.81	7.58	1.55	1.41	0.93
Accrued Expenses	27.18	14.76	9.43	5.36	3.76
Current Portion of Leases	0.65	0.58	0.69	0.45	0.35
Other Current Liabilities	0.5	-	-	6.4	7.35
Total Current Liabilities	42.14	22.92	11.67	13.62	12.38
Long-Term Leases	0.74	1.39	1.86	1.62	2.01
Other Long-Term Liabilities	6.52	3.98	4.01	-	1.36
Total Long-Term Liabilities	7.25	5.36	5.87	1.62	3.37
Total Liabilities	49.39	28.28	17.54	15.24	15.75

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	3.23	3.07	4.37	3.95	3.6
Treasury Stock	-	-	-0.02	-0.02	-0.02
Additional Paid-in Capital	66.87	64.84	87.18	173.23	169.56
Accumulated Other Comprehensive Income	31.76	27.56	26.44	23.06	22.25
Retained Earnings	-17.38	-31.05	-50.53	-125.74	-110.96
Shareholders' Equity	84.48	64.42	67.43	74.48	84.43
Total Liabilities & Equity	133.88	92.7	84.98	89.72	100.18

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.39	1.97	2.55	2.07	2.35
Net Cash (Debt)	18.38	17.8	14.35	23.96	29.04
Net Cash Growth	3.28%	24.05%	-40.13%	-17.50%	0.15%
Net Cash Per Share	0.44	0.48	0.39	0.71	0.89
Book Value	84.48	64.42	67.43	74.48	84.43
Book Value Per Share	2.04	1.73	1.84	2.20	2.57
Tangible Book Value	43.59	26.67	18.71	21.78	23.01
Tangible Book Value Per Share	1.05	0.72	0.51	0.64	0.70

Data Source: Fiscal.ai Last updated: Mar 10, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 2, 2026

Data Sources Report a data error